Orum Therapeutics
Biotechnology
Orum Therapeutics is a clinical-stage biopharmaceutical company developing targeted protein degradation therapeutics, specifically degrader-antibody conjugates (DACs), for cancer and immune diseases. The company leverages its proprietary TPD² platform to create cell-selective treatments.
- TPD²® (cell-selective targeted protein degradation)
- Degrader-antibody conjugates (DACs)
- ORM-1153 (CD123-targeting degrader-antibody conjugate)
Open roles at Orum Therapeutics
8 matching roles
Full-time · Executive
Daejeon, Daejeon, South Korea +1 more
- Chief Executives
- Finance
Posted 4 weeks ago
Source: BambooHR
Full-time
Lexington, Massachusetts, United States
- Biology
Posted 1 month ago
Source: BambooHR
Full-time · Manager
Daejeon, Daejeon, South Korea
- Management Occupations
- Finance
Posted 1 month ago
Source: BambooHR
Full-time · Director
Daejeon, Daejeon, South Korea
- Management Occupations
- Executive
Posted 2 months ago
Source: BambooHR
Full-time · Manager
Lexington, Massachusetts, United States
- Management Occupations
- Chemistry
Posted 2 months ago
Source: BambooHR
Full-time · Manager
Daejeon, Daejeon, South Korea +1 more
- Lawyers
- Legal
Posted 2 months ago
Source: BambooHR
Full-time
Lexington, Massachusetts, United States
- Chemistry
Posted 5 months ago
Source: BambooHR
Full-time · Lead
China
- Biology
Posted 1 month ago
Source: BambooHR
Showing 8 of 8 roles